DocuSign (DOCU) 10-Q 9 Jun 22 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Apr. 30, 2022	May 31, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2022
Document Transition Report	false
Entity File Number	001-38465
Entity Registrant Name	DOCUSIGN, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	91-2183967
Entity Address, Address Line One	221 Main St.
Entity Address, Address Line Two	Suite 1550
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	415
Local Phone Number	489-4940
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	DOCU
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		199,944,000
Entity Central Index Key	0001261333
Current Fiscal Year End Date	--01-31
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Current assets
Cash and cash equivalents	$ 638,190	$ 509,059
Investments—current	329,425	293,763
Accounts receivable, net of allowance for doubtful accounts of $5,076 and $5,807 as of April 30, 2022 and January 31, 2022	300,872	440,950
Contract assets—current	13,368	12,588
Prepaid expenses and other current assets	80,669	63,236
Total current assets	1,362,524	1,319,596
Investments—noncurrent	94,751	94,938
Property and equipment, net	183,704	184,664
Operating lease right-of-use assets	116,589	126,021
Goodwill	354,056	355,058
Intangible assets, net	87,277	98,816
Deferred contract acquisition costs—noncurrent	313,760	311,835
Other assets—noncurrent	61,470	50,337
Total assets	2,574,131	2,541,265
Current liabilities
Accounts payable	26,213	52,804
Accrued expenses and other current liabilities	92,936	91,377
Accrued compensation	137,724	160,163
Convertible senior notes—current	16	0
Contract liabilities—current	1,049,534	1,029,891
Operating lease liabilities—current	37,293	37,404
Total current liabilities	1,343,716	1,371,639
Convertible senior notes, net—noncurrent	719,616	718,487
Contract liabilities—noncurrent	15,794	16,725
Operating lease liabilities—noncurrent	114,976	126,340
Deferred tax liability—noncurrent	9,079	9,316
Other liabilities—noncurrent	22,001	23,255
Total liabilities	2,225,182	2,265,762
Commitments and contingencies (Note 7)
Stockholders’ equity
Preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of April 30, 2022 and January 31, 2022	0	0
Common stock, $0.0001 par value; 500,000 shares authorized, 199,920 shares outstanding as of April 30, 2022; 500,000 shares authorized, 198,834 shares outstanding as of January 31, 2022	20	20
Treasury stock, at cost: 8 and 7 shares as of April 30, 2022 and January 31, 2022	(1,648)	(1,532)
Additional paid-in capital	1,835,187	1,720,013
Accumulated other comprehensive loss	(19,048)	(4,809)
Accumulated deficit	(1,465,562)	(1,438,189)
Total stockholders’ equity	348,949	275,503
Total liabilities and stockholders' equity	$ 2,574,131	$ 2,541,265

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance for credit loss	$ 5,076	$ 5,807
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares outstanding (in shares)	199,920,000	198,834,000
Treasury stock, shares (in shares)	8,000	7,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Revenue:
Total revenue	$ 588,692	$ 469,078
Cost of revenue:
Total cost of revenue	132,416	105,242
Gross profit	456,276	363,836
Operating expenses:
Sales and marketing	300,697	239,119
Research and development	112,227	85,416
General and administrative	62,578	50,038
Total operating expenses	475,502	374,573
Loss from operations	(19,226)	(10,737)
Interest expense	(1,649)	(1,672)
Interest income and other income (expense), net	(4,650)	6,037
Loss before provision for income taxes	(25,525)	(6,372)
Provision for income taxes	1,848	1,982
Net loss	$ (27,373)	$ (8,354)
Net loss per share attributable to common stockholders, basic (in usd per share)	$ (0.14)	$ (0.04)
Net loss per share attributable to common stockholders, diluted (in usd per share)	$ (0.14)	$ (0.04)
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic (in shares)	199,666	194,342
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	199,666	194,342
Other comprehensive income (loss):
Foreign currency translation gain (loss), net of tax	$ (11,825)	$ 636
Unrealized losses on investments, net of tax	(2,414)	(242)
Other comprehensive income (loss)	(14,239)	394
Comprehensive loss	(41,612)	(7,960)
Stock-based compensation expense included in costs and expenses
Stock-based compensation expense	110,723	81,637
Sales and marketing
Stock-based compensation expense included in costs and expenses
Stock-based compensation expense	47,431	38,135
Research and development
Stock-based compensation expense included in costs and expenses
Stock-based compensation expense	32,205	20,462
General and administrative
Stock-based compensation expense included in costs and expenses
Stock-based compensation expense	15,392	10,986
Subscription
Revenue:
Total revenue	569,251	451,935
Cost of revenue:
Total cost of revenue	105,159	78,071
Subscription | Cost of revenue
Stock-based compensation expense included in costs and expenses
Stock-based compensation expense	10,613	6,018
Professional services and other
Revenue:
Total revenue	19,441	17,143
Cost of revenue:
Total cost of revenue	27,257	27,171
Professional services and other | Cost of revenue
Stock-based compensation expense included in costs and expenses
Stock-based compensation expense	$ 5,082	$ 5,535

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In CapitalCumulative Adjustment	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Accumulated DeficitCumulative Adjustment
Beginning balance (in shares) at Jan. 31, 2021			192,807
Beginning balance at Jan. 31, 2021	$ 325,737	$ (73,905)	$ 19	$ 1,702,254	$ (86,144)	$ (1,048)	$ 4,964	$ (1,380,452)	$ 12,239
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Settlement of convertible senior notes due 2023 (in shares)			352
Settlement of convertible senior notes due in 2023	(446)			(446)
Exercise of stock options (in shares)			488
Exercise of stock options	6,616			6,616
Settlement of restricted stock units (in shares)			955
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(113,583)			(113,412)		(171)
Employee stock purchase plan (in shares)			132
Employee stock purchase plan	23,167			23,167
Employee stock-based compensation expense	83,611			83,611
Net loss	(8,354)							(8,354)
Other comprehensive income (loss), net	394						394
Ending balance (in shares) at Apr. 30, 2021			194,734
Ending balance at Apr. 30, 2021	243,237		$ 19	1,615,646		(1,219)	5,358	(1,376,567)
Beginning balance (in shares) at Jan. 31, 2022			198,834
Beginning balance at Jan. 31, 2022	$ 275,503		$ 20	1,720,013		(1,532)	(4,809)	(1,438,189)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	179		179
Exercise of stock options	$ 1,938			1,938
Settlement of restricted stock units (in shares)			642
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(25,519)			(25,403)		(116)
Employee stock purchase plan (in shares)			265
Employee stock purchase plan	24,151			24,151
Employee stock-based compensation expense	114,488			114,488
Net loss	(27,373)							(27,373)
Other comprehensive income (loss), net	(14,239)						(14,239)
Ending balance (in shares) at Apr. 30, 2022			199,920
Ending balance at Apr. 30, 2022	$ 348,949		$ 20	$ 1,835,187		$ (1,648)	$ (19,048)	$ (1,465,562)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Apr. 30, 2022	Apr. 30, 2021
Cash flows from operating activities:
Net loss		$ (27,373)	$ (8,354)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		21,301	20,037
Amortization of deferred contract acquisition and fulfillment costs		43,990	30,933
Amortization of debt discount and transaction costs		1,284	1,319
Non-cash operating lease costs		6,442	6,943
Stock-based compensation expense		110,723	81,637
Deferred income taxes		72	264
Other		4,907	(6,359)
Changes in operating assets and liabilities:
Accounts receivable		140,078	73,205
Contract assets		(808)	1,607
Prepaid expenses and other current assets		(16,351)	(15,670)
Deferred contract acquisition and fulfillment costs		(50,512)	(46,154)
Other assets		(6,651)	(3,167)
Accounts payable		(23,197)	(21,593)
Accrued expenses and other liabilities		5,148	11,080
Accrued compensation		(23,220)	(34,048)
Contract liabilities		18,712	51,648
Operating lease liabilities		(8,259)	(7,731)
Net cash provided by operating activities		196,286	135,597
Cash flows from investing activities:
Purchases of marketable securities		(129,735)	(96,925)
Sales of marketable securities		0	2,002
Maturities of marketable securities		91,055	37,513
Purchases of strategic and other investments		(2,125)	(500)
Purchases of property and equipment		(21,709)	(12,596)
Net cash used in investing activities		(62,514)	(70,506)
Cash flows from financing activities:
Repayments of convertible senior notes		0	(36,684)
Payment of tax withholding obligation on net RSU settlement and ESPP purchase		(24,739)	(106,053)
Proceeds from exercise of stock options		1,938	6,616
Proceeds from employee stock purchase plan		24,151	23,167
Net cash (used in) provided by financing activities		1,350	(112,954)
Effect of foreign exchange on cash, cash equivalents and restricted cash		(5,180)	779
Net increase (decrease) in cash, cash equivalents and restricted cash		129,942	(47,084)
Cash, cash equivalents and restricted cash at beginning of period	[1]	509,679	566,336
Cash, cash equivalents and restricted cash at end of period	[1]	639,621	519,252
Supplemental disclosure:
Cash paid for interest		93	212
Cash paid for operating lease liabilities		10,423	9,888
Cash paid for income taxes		1,760	2,507
Non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities		5,358	1,275
Fair value of shares issued as part of the repayments of convertible senior notes		$ 0	$ 74,657
[1]	$1.4 million and $0.6 million of restricted cash was included in both Prepaid expenses and other current assets and Other assets—noncurrent at April 30, 2022 and January 31, 2022. $0.3 million of restricted cash was included in Other assets—noncurrent at April 30, 2021 and January 31, 2021.

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical) - USD ($) $ in Millions	Apr. 30, 2022	Jan. 31, 2022	Apr. 30, 2021	Jan. 31, 2021
Statement of Cash Flows [Abstract]
Restricted cash	$ 1.4	$ 0.6	$ 0.3	$ 0.3

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Organization and Description of Business DocuSign, Inc. (“we,” “our” or “us”) was incorporated in the State of Washington in April 2003. We merged with and into DocuSign, Inc., a Delaware corporation, in March 2015. We provide a platform that enables businesses of all sizes to digitally prepare, sign, act on and manage agreements, thereby simplifying and accelerating the process of doing business. Basis of Presentation and Principles of Consolidation Our condensed consolidated financial statements include those of DocuSign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying condensed consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our fiscal 2022 Annual Report on Form 10-K. Our condensed consolidated financial statements are unaudited and have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and, in our opinion, include all adjustments of a normal recurring nature necessary for the fair statement of our financial position, results of operations and cash flows. Our condensed consolidated balance sheet as of January 31, 2022 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations for the three months ended April 30, 2022 are not necessarily indicative of the results to be expected for the year ending January 31, 2023 . O ur fiscal year ends on January 3 1. References to fiscal 2023, for example, are to the fiscal year ending January 31, 2023 . Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the condensed consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the valuation of strategic investments; • the fair value of certain stock awards issued; • the f air value of convertible notes; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; and • the recognition, measurement and valuation of deferred income taxes. Since the emergence of the COVID-19 pandemic in March 2020, we have undertaken measures to protect our employees, partners and customers, including providing the majority of our employees the option to work remotely until at least February 1, 2023. However, there can be no assurance that these measures will be effective, that we will be able to adopt new measures as needed or that we will be able to discontinue these measures without adversely affecting our business operations. In addition, the COVID-19 pandemic and related recent developments (including the emergence of new coronavirus variants, the actions undertaken to contain the virus or mitigate its impacts, including actions mandated by governments and health authorities and changing public health directives or restrictions, vaccine efficacy against COVID-19 variants, current or future travel restrictions and how quickly and to what extent normal global economic and operating conditions can or will resume ) have created and may continue to create significant uncertainty in global financial markets, which may decrease technology spending, depress demand for our products and harm our business and results of operations. As of the date of issuance of the financial statements, we are not aware of any specific event or circumstance that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities, except for certain subleases that resulted in an impairment of $5.1 million on operating lease right-of-use assets recorded during the year ended January 31, 2022. These estimates may change as new events occur and additional information is obtained, which could be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to our financial statements. Significant Accounting Policies There have been no changes to our significant accounting policies described in our fiscal 2022 Annual Report on Form 10-K that have had a material impact on our condensed consolidated financial statements and related notes.

Revenue

Revenue	3 Months Ended
	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Subscription revenue is recognized over time and accounted for approximately 97% and 96% of our revenue for the three months ended April 30, 2022 and 2021. Performance Obligations As of April 30, 2022, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $1.6 billion. We expect to recognize 55% of the transaction price allocated to remaining performance obligations within the 12 months following April 30, 2022 in our condensed consolidated statement of operations and comprehensive loss. Contract Balances Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been fully invoiced to our customers where there remains a performance obligation, typically for our multi-year arrangements. Total contract assets were $13.4 million and $12.6 million as of April 30, 2022 and January 31, 2022. The change in contract assets reflects the difference in timing between the satisfaction of our remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the three months ended April 30, 2022 and 2021, we recognized revenue of $450.7 million and $357.8 million that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. Geographic Information Revenue by geography is based on the address of the customer as specified in our master subscription agreements with our customers. Revenue by geographic area was as follows: Three Months Ended April 30, (in thousands) 2022 2021 U.S. $ 444,453 $ 368,423 International 144,239 100,655 Total revenue $ 588,692 $ 469,078 The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Three Months Ended April 30, (in thousands) 2022 2021 Deferred Contract Acquisition Costs: Beginning balance $ 315,158 $ 262,519 Additions to deferred contract acquisition costs 38,286 39,700 Amortization of deferred contract acquisition costs (32,227) (25,842) Cumulative translation adjustment (2,903) 240 Ending balance $ 318,314 $ 276,617 Deferred Contract Fulfillment Costs: Beginning balance $ 19,088 $ 12,506 Additions to deferred contract fulfillment costs 12,226 6,454 Amortization of deferred contract fulfillment costs (11,763) (5,091) Cumulative translation adjustment (627) — Ending balance $ 18,924 $ 13,869

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Apr. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table summarizes our financial assets that are measured at fair value on a recurring basis: April 30, 2022 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 178 $ — $ — $ 178 Level 2: Cash equivalents (1) Commercial paper 66,452 — (13) 66,439 U.S. governmental securities 10,000 — — 10,000 Available-for-sale securities Commercial paper 118,361 — (513) 117,848 Corporate notes and bonds 272,963 2 (3,147) 269,818 U.S. governmental securities 36,799 — (289) 36,510 Level 2 total 504,575 2 (3,962) 500,615 Total $ 504,753 $ 2 $ (3,962) $ 500,793 January 31, 2022 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 110,716 $ — $ — $ 110,716 Level 2: Cash equivalents (1) Commercial paper 3,499 — — 3,499 Available-for-sale securities Commercial paper 126,371 1 (175) 126,197 Corporate notes and bonds 243,840 — (1,296) 242,544 U.S. governmental securities 20,036 — (76) 19,960 Level 2 total 393,746 1 (1,547) 392,200 Total $ 504,462 $ 1 $ (1,547) $ 502,916 (1) Included in “cash and cash equivalents” in our consolidated balance sheets as of April 30, 2022 and January 31, 2022, in addition to cash of $561.6 million and $394.9 million. We use quoted prices in active markets for identical assets to determine the fair value of our Level 1 investments. The fair value of our Level 2 investments is determined using pricing based on quoted market prices or alternative market observable inputs . The fair value of our Level 3 investments is determined based on an income approach using unobservable inputs. The fair value of our available-for-sale securities as of April 30, 2022, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 329,425 Due in one to two years 94,751 $ 424,176 As of April 30, 2022 and January 31, 2022, securities in an unrealized loss position were, individually and in aggregate, not material. An allowance for credit losses was deemed unnecessary for these securities, given the extent of the unrealized loss positions as well the issuers' high credit ratings and consistent payment history. We had no liabilities measured at fair value on a recurring basis as of April 30, 2022 and January 31, 2022. Strategic Investments During the three months ended April 30, 2022, investments in equity securities without readily determinable fair values increased by $0.3 million due to adjustments related to observable price changes that occurred during the quarter. Such investments are recorded in “Other assets—noncurrent” on our condensed consolidated balance sheets. Convertible Senior Notes We estimated the fair value of the convertible senior notes based on the quoted market prices in an inactive market on the last trading day of the reporting period (Level 2). The Notes are recorded at face value less unamortized debt discount and transaction costs as “Convertible senior notes—current” and “Convertible senior notes, net—noncurrent” on our condensed consolidated balance sheets. Refer to Note 6 for further information. (in thousands) April 30, 2022 January 31, 2022 0.5% Convertible Senior Notes due in 2023 Aggregate principal amount $ 37,099 $ 37,099 Fair value amount 42,664 65,440 0% Convertible Senior Notes due in 2024 Aggregate principal amount $ 690,000 $ 690,000 Fair value amount 644,460 656,363

Property and Equipment, Net

Property and Equipment, Net	3 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment consisted of the following: (in thousands) April 30, 2022 January 31, 2022 Computer and network equipment $ 132,220 $ 127,799 Software, including capitalized software development costs 84,483 82,537 Furniture and office equipment 20,905 20,939 Leasehold improvements 79,370 79,811 316,978 311,086 Less: Accumulated depreciation (180,800) (170,261) 136,178 140,825 Work in progress 47,526 43,839 Total $ 183,704 $ 184,664 Depreciation and amortization expense associated with property and equipment was $15.7 million and $13.5 million for the three months ended April 30, 2022 and 2021 . This included amortization expense related to capitalized internally-developed software costs of $4.3 million and $1.7 million for the three months ended April 30, 2022 and 2021 . For the three months ended April 30, 2022 and 2021,

Deferred Contract Acquisition a

Deferred Contract Acquisition and Fulfillment Costs	3 Months Ended
	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Deferred Contract Acquisition and Fulfillment Costs	Revenue Subscription revenue is recognized over time and accounted for approximately 97% and 96% of our revenue for the three months ended April 30, 2022 and 2021. Performance Obligations As of April 30, 2022, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $1.6 billion. We expect to recognize 55% of the transaction price allocated to remaining performance obligations within the 12 months following April 30, 2022 in our condensed consolidated statement of operations and comprehensive loss. Contract Balances Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been fully invoiced to our customers where there remains a performance obligation, typically for our multi-year arrangements. Total contract assets were $13.4 million and $12.6 million as of April 30, 2022 and January 31, 2022. The change in contract assets reflects the difference in timing between the satisfaction of our remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the three months ended April 30, 2022 and 2021, we recognized revenue of $450.7 million and $357.8 million that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. Geographic Information Revenue by geography is based on the address of the customer as specified in our master subscription agreements with our customers. Revenue by geographic area was as follows: Three Months Ended April 30, (in thousands) 2022 2021 U.S. $ 444,453 $ 368,423 International 144,239 100,655 Total revenue $ 588,692 $ 469,078 The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Three Months Ended April 30, (in thousands) 2022 2021 Deferred Contract Acquisition Costs: Beginning balance $ 315,158 $ 262,519 Additions to deferred contract acquisition costs 38,286 39,700 Amortization of deferred contract acquisition costs (32,227) (25,842) Cumulative translation adjustment (2,903) 240 Ending balance $ 318,314 $ 276,617 Deferred Contract Fulfillment Costs: Beginning balance $ 19,088 $ 12,506 Additions to deferred contract fulfillment costs 12,226 6,454 Amortization of deferred contract fulfillment costs (11,763) (5,091) Cumulative translation adjustment (627) — Ending balance $ 18,924 $ 13,869

Debt

Debt	3 Months Ended
	Apr. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt Convertible Senior Notes In September 2018 we issued $575.0 million in aggregate principal amount of the 0.5% Convertible Senior Notes due in 2023 (“2023 Notes”). The net proceeds from the issuance of the 2023 Notes were $560.8 million after deducting the initial purchasers’ discounts and transaction costs. Based upon the reported sales price of our common stock, the 2023 Notes became convertible on August 1, 2020 and continued to be convertible through April 30, 2022. In January 2021 we issued $690.0 million in aggregate principal amount of the 0% Convertible Senior Notes due in 2024 (“2024 Notes,” and together with the 2023 Notes, the “Notes”). The net proceeds from the issuance of the 2024 Notes were $677.3 million after deducting the initial purchasers’ discounts and transaction costs. As of April 30, 2022, the conversion conditions for the 2024 Notes described in our 2022 Annual Report on Form 10-K were not met. Conversions of the 2023 Notes As of April 30, 2022, we received conversion notices on our 2023 Notes for an immaterial amount. No settlements occurred during the three months ended April 30, 2022. Additionally, from May 1, 2022 to June 8, 2022, we had not received any conversion notices on our 2023 Notes. The net carrying amounts of the Notes were as follows: (in thousands) April 30, 2022 January 31, 2022 2023 Notes: Principal $ 37,099 $ 37,099 Less: unamortized transaction costs (255) (303) Net carrying value of current and noncurrent liability component $ 36,844 $ 36,796 2024 Notes: Principal $ 690,000 $ 690,000 Less: unamortized transaction costs (7,253) (8,309) Net carrying value of noncurrent liability component $ 682,747 $ 681,691 The effective interest rate on the 2023 Notes was 1.0%. The effective interest rate on the 2024 notes was 0.6%. Interest expense recognized related to the Notes was as follows: Three Months Ended April 30, (in thousands) 2022 2021 Contractual interest expense $ 46 $ 36 Amortization of transaction costs 1,101 1,181 Total $ 1,147 $ 1,217 Capped Calls To minimize the potential economic dilution to our common stock upon conversion of the Notes, we entered into privately-negotiated capped call transactions (“Capped Calls”) with certain counterparties. The material terms of the capped call transactions were as follows: (in thousands, except per share amounts) 2023 Notes 2024 Notes Aggregate cost of capped calls $ 67,563 $ 31,395 Initial strike price per share (1) $ 71.50 $ 420.24 Initial cap price per share (1) $ 110.00 $ 525.30 Shares of our common stock covered by the capped calls (1) 8,042 1,642 (1) Subject to adjustments for certain events, such as merger events and tender offers, and anti-dilution adjustments Impact on Loss Per Share In periods when we have net income, the shares of our common stock subject to the Notes outstanding during the period are included in our diluted earnings per share under the if-converted method. Capped Calls are excluded from the calculation of diluted earnings per share, as they would be antidilutive. Upon conversion, there will be no economic dilution from the Notes unless the market price of our common stock exceeds the cap prices listed above in the Capped Calls section, as exercise of the Capped Calls offsets any dilution from the Notes from the conversion price up to the cap price. As of April 30, 2022, the market price of our common stock did not exceed the $110.00 per share cap price associated with the 2023 Notes nor the $525.30 cap price associated with the 2024 Notes; therefore, the 2023 Notes would not have caused economic dilution if converted. Revolving Credit Facility In January 2021, we entered into a credit agreement with a syndicate of banks. The credit agreement extended a senior secured revolving credit facility (the “Credit Facility”) to us in an aggregate principal amount of $500.0 million, which amount may be increased by an additional $250.0 million subject to the terms of the credit agreement. We may use the proceeds of future borrowings under the credit facility to finance working capital, for capital expenditures and for other general corporate purposes, including permitted acquisitions.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies As of April 30, 2022, we had outstanding unused letters of credit associated with our various operating leases totaling $7.3 million. We have entered into certain noncancellable contractual arrangements that require future purchases of goods and services. These arrangements primarily relate to cloud infrastructure support and sales and marketing activities. As of April 30, 2022, the future noncancellable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2023, remainder $ 50,468 2024 57,517 2025 21,903 2026 9,397 2027 2,694 Thereafter 2,015 Total $ 143,994 In May 2022, the Company entered into an agreement with a public cloud computing service provider for a five-year commitment of $175.0 million. Indemnification We enter into indemnification provisions under our agreements with customers and other companies in the ordinary course of business, including business partners, contractors and parties performing our research and development. Pursuant to these arrangements, we agree to indemnify and defend the indemnified party for certain claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claims because of our activities. The duration of these indemnification agreements is generally perpetual. The maximum potential amount of future payments we could be required to make under these indemnification clauses or agreements is not determinable. Historically, we have not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the fair value of these indemnification agreements is not material as of April 30, 2022, and January 31, 2022. We maintain commercial general liability insurance and product liability insurance to offset certain of our potential liabilities under these indemnification agreements. We have entered into indemnification agreements with each of our directors, executive officers and certain other officers. These agreements require us to indemnify such individuals, to the fullest extent permitted by Delaware law, for certain liabilities to which they may become subject as a result of their affiliation with us. Claims and Litigation From time to time, we may be subject to legal proceedings, claims and litigation made against us in the ordinary course of business. We believe the final outcome of these matters will not have a material adverse effect on our business, consolidated financial position, results of operations or cash flows. DocuSign, Inc. Securities Litigation and Related Derivative Litigation On February 8, 2022, a putative securities class action was filed in the U.S. District Court for the Northern District of California, captioned Weston v. DocuSign, Inc., et al., Case No. 3:22-cv-00824, naming DocuSign and certain of our current and former officers as defendants. The complaint purports to allege claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, based on allegedly false and misleading statements about our business and prospects during the course of the COVID-19 pandemic. The suit is purportedly brought on behalf of purchasers of our securities between June 4, 2020 and December 2, 2021. We are not yet required to respond to the complaint, but believe it is devoid of merit. An earlier action alleging similar claims against the same defendants, captioned Collins v. DocuSign, Inc., et al., Case No. 3:22-cv-00851, filed in the Eastern District of New York and subsequently transferred to the Northern District of California, was voluntarily dismissed on February 14, 2022. Three putative shareholder derivative cases have been filed containing allegations based on or similar to those in the securities class action. The cases were filed on May 17, 2022, in the U.S. District Court for the District of Delaware, captioned Potteti v. Springer, et al., Case No. 1:22-cv-00652; on May 19, 2022 in the U.S. District Court for the Northern District of California, captioned Lapin v. Springer, et al., Case No. 3:22-cv-02980; and on May 20, 2022, also in the U.S. District Court for the Northern District of California, captioned Votto v. Springer, et al., Case No. 3:22-cv-02987. Each case is allegedly brought on the Company’s behalf. The suits name the Company as a nominal defendant and, depending on the particular case, the members of our board of directors or, in certain instances, current or former officers, as defendants. While the complaints vary, they are based largely on the same allegations as the securities class action suit described above, including allegations relating to our disclosures between June 4, 2020 and December 2, 2021 as well as, in certain instances, alleged insider trading. Collectively, these lawsuits purport to assert claims for, among other things, breach of fiduciary duty, aiding and abetting such breach, corporate waste, unjust enrichment, and under Sections 10(b) and 21D of the Securities Exchange Act of 1934. The Complaints seek to recover unspecified damages and other relief on the Company’s behalf. We are not yet required to respond to any of these derivative suits.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Apr. 30, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Equity Incentive Plans We maintain three stock-based compensation plans: the 2018 Equity Incentive Plan (the “2018 Plan”), the Amended and Restated 2011 Equity Incentive Plan (the “2011 Plan”) and the Amended and Restated 2003 Stock Plan (the “2003 Plan”). As of April 30, 2022, 50.7 million shares of our common stock were available for issuance under the 2018 Plan. Restricted Stock Units Restricted stock unit (“RSU”) activity for the three months ended April 30, 2022 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2022 7,843 $ 146.52 Granted 2,459 97.19 Vested (978) 97.59 Canceled (639) 139.40 Unvested at April 30, 2022 8,685 $ 138.68 As of April 30, 2022, our total unrecognized compensation cost related to RSUs was $911.6 million. We expect to recognize this expense over the remaining weighted-average period of approximately 2.3 years. We have $49.4 million and $55.7 million of unvested RSUs that are subject to market-based vesting conditions as of April 30, 2022 and January 31, 2022. Stock Options Option activity for the three months ended April 30, 2022 was as follows: (in thousands, except years and per share data) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2022, all vested and exercisable 3,105 $ 16.41 4.45 $ 339,286 Exercised (179) 10.94 Outstanding at April 30, 2022, all vested and exercisable 2,926 $ 16.74 4.30 $ 187,884 As of April 30, 2022, there was no remaining unrecognized compensation cost related to stock option grants. 2018 Employee Stock Purchase Plan The Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase shares of our common stock at a discounted price, normally through payroll deductions, subject to the terms of the ESPP and applicable law. As of April 30, 2022, 9.7 million shares of our common stock were reserved for issuance under the ESPP. Compensation expense related to the ESPP was $5.0 million and $4.3 million for the three months ended April 30, 2022 and 2021.

Net Loss per Share Attributable

Net Loss per Share Attributable to Common Stockholders	3 Months Ended
	Apr. 30, 2022
Earnings Per Share [Abstract]
Net Loss per Share Attributable to Common Stockholders	Net Loss per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders for periods presented: Three Months Ended April 30, (in thousands, except per share data) 2022 2021 Numerator: Net loss attributable to common stockholders $ (27,373) $ (8,354) Denominator: Weighted-average common shares outstanding 199,666 194,342 Net loss per share attributable to common stockholders: Basic and diluted $ (0.14) $ (0.04) Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: April 30, (in thousands) 2022 2021 RSUs 8,685 9,194 Stock options 2,926 4,310 ESPP 437 158 Convertible senior notes 2,161 2,737 Total antidilutive securities 14,209 16,399

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesOur tax provision from income taxes for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, we update our estimate of the annual effective tax rate, and if our estimated tax rate changes, we make a cumulative adjustment. There were no material discrete items in the quarter. Our income tax provision was $1.8 million and $2.0 million for the three months ended April 30, 2022 and 2021. We review the likelihood that we will realize the benefit of our deferred tax assets and, therefore, the need for valuation allowances, on a quarterly basis. We maintain a valuation allowance against certain deferred tax assets, including all U.S. consolidated group deferred tax assets and certain foreign deferred tax assets as a result of our history of losses in the U.S. and certain foreign jurisdictions, and the variability and uncertainty of our operating results. In the event we determine our deferred tax assets are realizable based on our assessment of relevant factors, an adjustment to the valuation allowance may increase income in the period such determination is made. As of April 30, 2022, our gross unrecognized tax benefits totaled $48.1 million, excluding related accrued interest and penalties, of which $14.1 million would impact the effective tax rate if recognized. Our policy is to account for interest and penalties related to uncertain tax positions as a component of income tax provision. We do not expect to have any significant changes to unrecognized tax benefits during the next twelve months. We are subject to taxation in the U.S. and various foreign jurisdictions. Our tax years from inception in 2003 through April 30, 2022 remain subject to examination by U.S. and California taxing authorities, as well as taxing authorities in various other state and foreign jurisdictions. We are under examination by the Israel Tax Authority for the period January 1, 2016 through January 31, 2021. We are not under examination in any other material jurisdiction. We believe that adequate amounts have been reserved in all jurisdictions.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Basis of Presentation and Principles of Consolidation Our condensed consolidated financial statements include those of DocuSign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying condensed consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our fiscal 2022 Annual Report on Form 10-K.
Basis of Presentation	Our condensed consolidated financial statements are unaudited and have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and, in our opinion, include all adjustments of a normal recurring nature necessary for the fair statement of our financial position, results of operations and cash flows. Our condensed consolidated balance sheet as of January 31, 2022 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations for the three months ended April 30, 2022 are not necessarily indicative of the results to be expected for the year ending January 31, 2023 .
Fiscal Year	O ur fiscal year ends on January 3 1. References to fiscal 2023, for example, are to the fiscal year ending January 31, 2023 .
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the condensed consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the valuation of strategic investments; • the fair value of certain stock awards issued; • the f air value of convertible notes; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; and • the recognition, measurement and valuation of deferred income taxes.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenues by geographic area	Revenue by geographic area was as follows: Three Months Ended April 30, (in thousands) 2022 2021 U.S. $ 444,453 $ 368,423 International 144,239 100,655 Total revenue $ 588,692 $ 469,078

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Apr. 30, 2022
Fair Value Disclosures [Abstract]
Summary of assets and liabilities measured at fair value on a recurring basis	The following table summarizes our financial assets that are measured at fair value on a recurring basis: April 30, 2022 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 178 $ — $ — $ 178 Level 2: Cash equivalents (1) Commercial paper 66,452 — (13) 66,439 U.S. governmental securities 10,000 — — 10,000 Available-for-sale securities Commercial paper 118,361 — (513) 117,848 Corporate notes and bonds 272,963 2 (3,147) 269,818 U.S. governmental securities 36,799 — (289) 36,510 Level 2 total 504,575 2 (3,962) 500,615 Total $ 504,753 $ 2 $ (3,962) $ 500,793 January 31, 2022 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 110,716 $ — $ — $ 110,716 Level 2: Cash equivalents (1) Commercial paper 3,499 — — 3,499 Available-for-sale securities Commercial paper 126,371 1 (175) 126,197 Corporate notes and bonds 243,840 — (1,296) 242,544 U.S. governmental securities 20,036 — (76) 19,960 Level 2 total 393,746 1 (1,547) 392,200 Total $ 504,462 $ 1 $ (1,547) $ 502,916 (1) Included in “cash and cash equivalents” in our consolidated balance sheets as of April 30, 2022 and January 31, 2022, in addition to cash of $561.6 million and $394.9 million.
Fair value of available-for-sale marketable securities by remaining contractual maturities	The fair value of our available-for-sale securities as of April 30, 2022, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 329,425 Due in one to two years 94,751 $ 424,176
Schedule of convertible senior notes	(in thousands) April 30, 2022 January 31, 2022 0.5% Convertible Senior Notes due in 2023 Aggregate principal amount $ 37,099 $ 37,099 Fair value amount 42,664 65,440 0% Convertible Senior Notes due in 2024 Aggregate principal amount $ 690,000 $ 690,000 Fair value amount 644,460 656,363

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	3 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
Property and equipment	Property and equipment consisted of the following: (in thousands) April 30, 2022 January 31, 2022 Computer and network equipment $ 132,220 $ 127,799 Software, including capitalized software development costs 84,483 82,537 Furniture and office equipment 20,905 20,939 Leasehold improvements 79,370 79,811 316,978 311,086 Less: Accumulated depreciation (180,800) (170,261) 136,178 140,825 Work in progress 47,526 43,839 Total $ 183,704 $ 184,664

Deferred Contract Acquisition_2

Deferred Contract Acquisition and Fulfillment Costs (Tables)	3 Months Ended
	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Deferred contract costs	The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Three Months Ended April 30, (in thousands) 2022 2021 Deferred Contract Acquisition Costs: Beginning balance $ 315,158 $ 262,519 Additions to deferred contract acquisition costs 38,286 39,700 Amortization of deferred contract acquisition costs (32,227) (25,842) Cumulative translation adjustment (2,903) 240 Ending balance $ 318,314 $ 276,617 Deferred Contract Fulfillment Costs: Beginning balance $ 19,088 $ 12,506 Additions to deferred contract fulfillment costs 12,226 6,454 Amortization of deferred contract fulfillment costs (11,763) (5,091) Cumulative translation adjustment (627) — Ending balance $ 18,924 $ 13,869

Debt (Tables)

Debt (Tables)	3 Months Ended
	Apr. 30, 2022
Debt Disclosure [Abstract]
Schedule of convertible debt	The net carrying amounts of the Notes were as follows: (in thousands) April 30, 2022 January 31, 2022 2023 Notes: Principal $ 37,099 $ 37,099 Less: unamortized transaction costs (255) (303) Net carrying value of current and noncurrent liability component $ 36,844 $ 36,796 2024 Notes: Principal $ 690,000 $ 690,000 Less: unamortized transaction costs (7,253) (8,309) Net carrying value of noncurrent liability component $ 682,747 $ 681,691 Three Months Ended April 30, (in thousands) 2022 2021 Contractual interest expense $ 46 $ 36 Amortization of transaction costs 1,101 1,181 Total $ 1,147 $ 1,217
Schedule of capped calls	The material terms of the capped call transactions were as follows: (in thousands, except per share amounts) 2023 Notes 2024 Notes Aggregate cost of capped calls $ 67,563 $ 31,395 Initial strike price per share (1) $ 71.50 $ 420.24 Initial cap price per share (1) $ 110.00 $ 525.30 Shares of our common stock covered by the capped calls (1) 8,042 1,642 (1) Subject to adjustments for certain events, such as merger events and tender offers, and anti-dilution adjustments

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of noncancelable contractual obligations	As of April 30, 2022, the future noncancellable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2023, remainder $ 50,468 2024 57,517 2025 21,903 2026 9,397 2027 2,694 Thereafter 2,015 Total $ 143,994

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Apr. 30, 2022
Equity [Abstract]
Schedule of RSU activity	Restricted stock unit (“RSU”) activity for the three months ended April 30, 2022 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2022 7,843 $ 146.52 Granted 2,459 97.19 Vested (978) 97.59 Canceled (639) 139.40 Unvested at April 30, 2022 8,685 $ 138.68
Schedule of stock option activity	Option activity for the three months ended April 30, 2022 was as follows: (in thousands, except years and per share data) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2022, all vested and exercisable 3,105 $ 16.41 4.45 $ 339,286 Exercised (179) 10.94 Outstanding at April 30, 2022, all vested and exercisable 2,926 $ 16.74 4.30 $ 187,884

Net Loss per Share Attributab_2

Net Loss per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Apr. 30, 2022
Earnings Per Share [Abstract]
Schedule of calculation of basic and diluted loss per share	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders for periods presented: Three Months Ended April 30, (in thousands, except per share data) 2022 2021 Numerator: Net loss attributable to common stockholders $ (27,373) $ (8,354) Denominator: Weighted-average common shares outstanding 199,666 194,342 Net loss per share attributable to common stockholders: Basic and diluted $ (0.14) $ (0.04)
Schedule of antidilutive securities	Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: April 30, (in thousands) 2022 2021 RSUs 8,685 9,194 Stock options 2,926 4,310 ESPP 437 158 Convertible senior notes 2,161 2,737 Total antidilutive securities 14,209 16,399

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) $ in Millions	12 Months Ended
	Jan. 31, 2021USD ($)
Accounting Policies [Abstract]
Operating lease, impairment loss	$ 5.1

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 1,600
Contract assets	13.4		$ 12.6
Revenue recognized that was included in contract liability balance at the beginning of the period	$ 450.7	$ 357.8
Payment term	30 days
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-05-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	55.00%
Remaining performance obligations, period of recognition	12 months
Product concentration risk | Revenue | Subscription
Disaggregation of Revenue [Line Items]
Concentration risk percentage	97.00%	96.00%

Revenue - Revenue by Geographic

Revenue - Revenue by Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 588,692	$ 469,078
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	444,453	368,423
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 144,239	$ 100,655

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	$ 504,753	$ 504,462
Gross Unrealized Gains	2	1
Gross Unrealized Losses	(3,962)	(1,547)
Estimated Fair Value	500,793	502,916
Cash	561,600	394,900
Short-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Fair Value	424,176
Level 2 | Short-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	504,575	393,746
Gross Unrealized Gains	2	1
Gross Unrealized Losses	(3,962)	(1,547)
Estimated Fair Value	500,615	392,200
Commercial paper | Level 2 | Cash and Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	66,452	3,499
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(13)	0
Estimated Fair Value	66,439	3,499
Commercial paper | Level 2 | Short-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	118,361	126,371
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(513)	(175)
Estimated Fair Value	117,848	126,197
U.S. governmental securities | Level 2 | Cash and Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	10,000
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	10,000
U.S. governmental securities | Level 2 | Short-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	36,799	20,036
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(289)	(76)
Estimated Fair Value	36,510	19,960
Corporate notes and bonds | Level 2 | Short-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	272,963	243,840
Gross Unrealized Gains	2	0
Gross Unrealized Losses	(3,147)	(1,296)
Estimated Fair Value	269,818	242,544
Money market funds | Level 1 | Cash and Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	178	110,716
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	$ 178	$ 110,716

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Available-for-Sale Marketable Securities by Remaining Contractual Maturities (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total available-for-sale securities	$ 500,793	$ 502,916
Short-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Due in one year or less	329,425
Due in one to two years	94,751
Total available-for-sale securities	$ 424,176

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($)	3 Months Ended
	Apr. 30, 2022	Jan. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Equity securities without readily determinable fair value, upward price adjustment	$ 300,000
Fair Value, Recurring
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities measured at fair value on a recurring basis	$ 0	$ 0

Fair Value Measurements - Fai_2

Fair Value Measurements - Fair Value of Convertible Notes (Details) - Convertible Debt - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022	Jan. 31, 2021	Sep. 30, 2018
Convertible Senior Notes Due 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Principal	$ 37,099	$ 37,099
Fair value amount	42,664	65,440
Debt interest rate percentage				0.50%
Convertible Senior Notes Due 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Principal	690,000	690,000
Fair value amount	$ 644,460	$ 656,363
Debt interest rate percentage			0.00%

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 183,704		$ 184,664
Depreciation expense	15,700	$ 13,500
Capitalized computer software, amortization	4,300	1,700
Capitalized software costs	10,500	7,800
Capitalized stock-based compensation	2,800	$ 2,000
Property and equipment, excluding work in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	316,978		311,086
Less: Accumulated depreciation	(180,800)		(170,261)
Property and equipment, net	136,178		140,825
Computer and network equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	132,220		127,799
Software, including capitalized software development costs
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	84,483		82,537
Furniture and office equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	20,905		20,939
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	79,370		79,811
Work in progress
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 47,526		$ 43,839

Deferred Contract Acquisition_3

Deferred Contract Acquisition and Fulfillment Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Capitalized Contract Cost, Net [Roll Forward]
Amortization of deferred contract acquisition costs	$ (43,990)	$ (30,933)
Deferred Contract Acquisition Costs:
Capitalized Contract Cost, Net [Roll Forward]
Beginning balance	315,158	262,519
Additions to deferred contract acquisition costs	38,286	39,700
Amortization of deferred contract acquisition costs	(32,227)	(25,842)
Cumulative translation adjustment	(2,903)	240
Ending balance	318,314	276,617
Deferred Contract Fulfillment Costs:
Capitalized Contract Cost, Net [Roll Forward]
Beginning balance	19,088	12,506
Additions to deferred contract acquisition costs	12,226	6,454
Amortization of deferred contract acquisition costs	(11,763)	(5,091)
Cumulative translation adjustment	(627)	0
Ending balance	$ 18,924	$ 13,869

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	1 Months Ended		3 Months Ended
	Jan. 31, 2021	Sep. 30, 2018	Apr. 30, 2022
Convertible Senior Notes Due 2023 | Capped Calls
Debt Conversion [Line Items]
Initial cap price (in usd per share)			$ 110
Convertible Senior Notes Due 2023 | Convertible Debt
Debt Conversion [Line Items]
Principle on face amount of debt		$ 575,000,000
Debt interest rate percentage		0.50%
Proceeds from issuance of debt		$ 560,800,000
Aggregate amount of principle settled			$ 0
Debt instrument, effective interest rate	1.00%
Convertible Senior Notes Due 2023 | Convertible Debt | Capped Calls
Debt Conversion [Line Items]
Initial cap price (in usd per share)			$ 110
Convertible Senior Notes Due 2024 | Capped Calls
Debt Conversion [Line Items]
Initial cap price (in usd per share)			525.30
Convertible Senior Notes Due 2024 | Convertible Debt
Debt Conversion [Line Items]
Principle on face amount of debt	$ 690,000,000
Debt interest rate percentage	0.00%
Proceeds from issuance of debt	$ 677,300,000
Debt instrument, effective interest rate	0.60%
Convertible Senior Notes Due 2024 | Convertible Debt | Capped Calls
Debt Conversion [Line Items]
Initial cap price (in usd per share)			$ 525.30
Credit Facility | Revolving Credit Facility
Debt Conversion [Line Items]
Line of credit, maximum borrowing capacity	$ 500,000,000
Line of credit, additional borrowing amount	$ 250,000,000
Credit Facility | Revolving Credit Facility | Minimum
Debt Conversion [Line Items]
Line of credit, commitment fee percentage on undrawn balance			0.25%
Credit Facility | Revolving Credit Facility | Maximum
Debt Conversion [Line Items]
Line of credit, commitment fee percentage on undrawn balance			0.30%

Debt - Carrying Value of Liabil

Debt - Carrying Value of Liability Component (Details) - Convertible Debt - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Convertible Senior Notes Due 2023
Debt Instrument [Line Items]
Principal	$ 37,099	$ 37,099
Less: unamortized transaction costs	(255)	(303)
Net carrying value of current and noncurrent liability component	36,844	36,796
Convertible Senior Notes Due 2024
Debt Instrument [Line Items]
Principal	690,000	690,000
Less: unamortized transaction costs	(7,253)	(8,309)
Net carrying value of current and noncurrent liability component	$ 682,747	$ 681,691

Debt - Interest Expense (Detail

Debt - Interest Expense (Details) - Convertible Debt - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Debt Instrument [Line Items]
Contractual interest expense	$ 46	$ 36
Amortization of transaction costs	1,101	1,181
Total	$ 1,147	$ 1,217

Debt - Schedule of Capped Calls

Debt - Schedule of Capped Calls (Details) - Capped Calls $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2022USD ($)$ / sharesshares
Convertible Senior Notes Due 2023
Option Indexed to Issuer's Equity [Line Items]
Initial cap price (in usd per share)	$ 110
Convertible Senior Notes Due 2024
Option Indexed to Issuer's Equity [Line Items]
Initial cap price (in usd per share)	$ 525.30
Convertible Debt | Convertible Senior Notes Due 2023
Option Indexed to Issuer's Equity [Line Items]
Aggregate cost of capped calls | $	$ 67,563
Initial strike price (in usd per share)	$ 71.50
Initial cap price (in usd per share)	$ 110
Shares covered by capped calls (in shares) | shares	8,042
Convertible Debt | Convertible Senior Notes Due 2024
Option Indexed to Issuer's Equity [Line Items]
Aggregate cost of capped calls | $	$ 31,395
Initial strike price (in usd per share)	$ 420.24
Initial cap price (in usd per share)	$ 525.30
Shares covered by capped calls (in shares) | shares	1,642

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended
	May 31, 2022	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding		$ 7,300
Subsequent Event [Line Items]
Minimum commitment		$ 143,994
Subsequent Event
Subsequent Event [Line Items]
Purchase commitment, term	5 years
Minimum commitment	$ 175,000

Commitments and Contingencies_2

Commitments and Contingencies - Future Purchase Obligations (Details) $ in Thousands	Apr. 30, 2022USD ($)
Purchase Obligation, Fiscal Year Maturity [Abstract]
2023, remainder	$ 50,468
2024	57,517
2025	21,903
2026	9,397
2027	2,694
Thereafter	2,015
Total	$ 143,994

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) shares in Thousands	3 Months Ended
	Apr. 30, 2022USD ($)planshares	Apr. 30, 2021USD ($)	Jan. 31, 2022shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock-based compensation plans | plan	3
Unrecognized compensation cost, options | $	$ 0
Employee stock purchase plan, compensation expense | $	110,723,000	$ 81,637,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, RSUs | $	$ 911,600,000
Unrecognized compensation cost, remaining weighted-average period for recognition	2 years 3 months 18 days
RSUs outstanding (in shares) | shares	8,685		7,843
RSUs | Market Based Vesting Conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs outstanding (in shares) | shares	49,400		55,700
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee stock purchase plan, compensation expense | $	$ 5,000,000	$ 4,300,000
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares) | shares	50,700
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares) | shares	9,700

Stockholders' Equity - RSU Acti

Stockholders' Equity - RSU Activity (Details) - RSUs shares in Thousands	3 Months Ended
	Apr. 30, 2022$ / sharesshares
Number of Units
Unvested at beginning of period (in shares) | shares	7,843
Granted (in shares) | shares	2,459
Vested (in shares) | shares	(978)
Canceled (in shares) | shares	(639)
Unvested at end of period (in shares) | shares	8,685
Weighted-Average Grant Date Fair Value
Unvested at beginning of period (in usd per share) | $ / shares	$ 146.52
Granted (in usd per share) | $ / shares	97.19
Vested (in usd per share) | $ / shares	97.59
Canceled (in usd per share) | $ / shares	139.40
Unvested at end of period (in usd per share) | $ / shares	$ 138.68

Stockholders' Equity - Stock Op

Stockholders' Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2022	Jan. 31, 2022
Number of Options
Beginning balance (in shares)	3,105
Options exercised (in shares)	(179)
Ending balance (in shares)	2,926	3,105
Weighted-Average Exercise Price Per Share
Beginning balance (in usd per share)	$ 16.41
Options exercised (in usd per share)	10.94
Ending balance (in usd per share)	$ 16.74	$ 16.41
Weighted-Average Remaining Contractual Term (Years)
Outstanding balance	4 years 3 months 18 days	4 years 5 months 12 days
Aggregate Intrinsic Value
Outstanding balance	$ 187,884	$ 339,286

Net Loss per Share Attributab_3

Net Loss per Share Attributable to Common Stockholders - Calculation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Numerator:
Net loss attributable to common stockholders, basic	$ (27,373)	$ (8,354)
Net loss attributable to common stockholders, diluted	$ (27,373)	$ (8,354)
Denominator:
Weighted-average common shares outstanding, basic (in shares)	199,666	194,342
Weighted-average common shares outstanding, diluted (in shares)	199,666	194,342
Net loss per share attributable to common stockholders:
Basic (in usd per share)	$ (0.14)	$ (0.04)
Diluted (in usd per share)	$ (0.14)	$ (0.04)

Net Loss per Share Attributab_4

Net Loss per Share Attributable to Common Stockholders - Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	14,209	16,399
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	8,685	9,194
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	2,926	4,310
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	437	158
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	2,161	2,737

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 1,848	$ 1,982
Unrecognized tax benefits	48,100
Unrecognized tax benefits that would impact effective tax rate	$ 14,100

Uncategorized Items - docu-2022

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]